According to Zhitong Finance App News, Jet Biotech (688026.SH) released its report for the first quarter of 2024. During the reporting period, the company achieved operating income of 98.2753 million yuan, an increase of 32.30%; net profit attributable to shareholders of listed companies was 8.178,500 yuan, an increase of 192.97% year on year; net profit attributable to shareholders of listed companies deducted non-recurring profit and loss of 4.2383 million yuan, an increase of 142.15% year on year; basic earnings per share were 0.07 yuan/share.